|
Apr 10
|
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
|
|
Apr 9
|
Apple, Alibaba, drugmaker stocks: Trending Tickers
|
|
Apr 9
|
Trump says pharmaceutical tariffs may be coming: What to know
|
|
Apr 9
|
Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan
|
|
Apr 9
|
Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance
|
|
Feb 18
|
WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
|
|
Feb 11
|
Health Canada Approves Merck's KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant trea...
|